Literature DB >> 21699820

Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.

Harjit K Bhogal1, Arun J Sanyal.   

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) decompresses the portal venous system. TIPS has been used to manage the complications of portal hypertension in cirrhosis, including variceal hemorrhage and refractory ascites. The uncoated TIPS stents are limited by stent stenosis; however, the introduction of coated stents has decreased this. With the introduction of coated stents, we must reevaluate the utility of TIPS in the management of complications of portal hypertension.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21699820      PMCID： PMC3200495          DOI： 10.1016/j.cgh.2011.06.013

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  85 in total

Review 1.  Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.

Authors:  P Deltenre; P Mathurin; S Dharancy; R Moreau; P Bulois; J Henrion; F R Pruvot; O Ernst; J C Paris; D Lebrec
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

2.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

3.  Experimental cryoprobe production of intrahepatic portocaval shunt.

Authors:  M Reich; F Olumide; E Jorgensen; B Eiseman
Journal:  J Surg Res       Date:  1977-07       Impact factor: 2.192

4.  TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.

Authors:  Antonia Perelló; Juan Carlos García-Pagán; Rosa Gilabert; Yanette Suárez; Eduardo Moitinho; Francisco Cervantes; Juan Carlos Reverter; Angels Escorsell; Jaume Bosch; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

5.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.

Authors:  M A Jeffries; S Kazanjian; M Wilson; J Punch; R J Fontana
Journal:  Liver Transpl Surg       Date:  1998-09

7.  Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.

Authors:  Gennaro D'Amico; Roberto De Franchis
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

8.  Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Authors:  A J Sanyal; A M Freedman; M L Shiffman; P P Purdum; V A Luketic; A K Cheatham
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

9.  TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience.

Authors:  Andrea Mancuso; Konrad Fung; Maria Mela; John Tibballs; Anthony Watkinson; Andrew K Burroughs; David Patch
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

10.  Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.

Authors:  Christophe Bureau; Juan Carlos Garcia Pagan; Gilles Pomier Layrargues; Sophie Metivier; Pablo Bellot; Pierre Perreault; Philippe Otal; Juan-G Abraldes; Jean Marie Peron; Hervé Rousseau; Jaume Bosch; Jean Pierre Vinel
Journal:  Liver Int       Date:  2007-08       Impact factor: 5.828
View more
  8 in total

1.  Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).

Authors:  Sergio Maimone; Francesca Saffioti; Roberto Filomia; Angela Alibrandi; Grazia Isgrò; Vincenza Calvaruso; Elias Xirouchakis; Gian Piero Guerrini; Andrew K Burroughs; Emmanuel Tsochatzis; David Patch
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

Review 2.  Transjugular intrahepatic portosystemic shunt: An overview.

Authors:  Harjit K Bhogal; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

3.  Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.

Authors:  Mona Ascha; Mohamad Hanouneh; Mustafa S Ascha; Nizar N Zein; Mark Sands; Rocio Lopez; Ibrahim A Hanouneh
Journal:  Dig Dis Sci       Date:  2016-05-06       Impact factor: 3.199

Review 4.  Transjugular intrahepatic portosystemic shunt.

Authors:  Kavish R Patidar; Malcolm Sydnor; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2014-08-27       Impact factor: 6.126

Review 5.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 6.  Outcomes of transjugular intrahepatic portosystemic shunts for ascites.

Authors:  Zachary L Bercu; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

7.  Do cirrhotic patients with a high MELD score benefit from TIPS?

Authors:  Won Hyeok Choe
Journal:  Clin Mol Hepatol       Date:  2014-03-26

8.  Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Authors:  Dengke Teng; Hao Zuo; Lin Liu; Jinghui Dong; Lei Ding
Journal:  Virol J       Date:  2018-10-01       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.